Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jandrain

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal De Pharmacie De Belgique|July 1, 1996
[Treatment of obesity: are drug combinations effective?]B Jandrain
Revue Medicale De Liege|May 15, 1985
[A case of polymer fever]B Jandrain, M Radermecker
Revue Medicale De Liege|April 11, 2002
[How I explore ... the risk of a patient developing type 2 diabetes]A J Scheen, N Paquot, B Jandrain
Revue Medicale De Liege|December 23, 2017
[Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors]A J Scheen, Ph Ernest, B Jandrain
Revue Medicale De Liege|August 20, 2015
[STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE]Ph Ernest, B Jandrain, A J Scheen
Revue Medicale De Liege|January 26, 2013
[How I explore ... a risk difference in the occurrence of an event in clinical trials]A J Scheen, P Ernest, B Jandrain
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1990
[Eating before, during and after physical exercise in normal and diabetic subjects]B Jandrain, P Lefebvre, F Pirnay, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1992
[Postprandial hypoglycemia and alcohol drinking]P J Lefebvre, B Jandrain, A J Scheen
Diabete & Metabolisme|March 1, 1988
[Adaptation to sports by insulin-treated diabetics]B Jandrain, F Pirnay, A Scheen, et al.
The American Journal of Medicine|April 27, 1992
Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertensionB Jandrain, C Herbaut, J C Depoorter, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal De Pharmacie De Belgique|July 1, 1996
[Treatment of obesity: are drug combinations effective?]B Jandrain
Revue Medicale De Liege|May 15, 1985
[A case of polymer fever]B Jandrain, M Radermecker
Revue Medicale De Liege|April 11, 2002
[How I explore ... the risk of a patient developing type 2 diabetes]A J Scheen, N Paquot, B Jandrain
Revue Medicale De Liege|December 23, 2017
[Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors]A J Scheen, Ph Ernest, B Jandrain
Revue Medicale De Liege|August 20, 2015
[STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE]Ph Ernest, B Jandrain, A J Scheen
Revue Medicale De Liege|January 26, 2013
[How I explore ... a risk difference in the occurrence of an event in clinical trials]A J Scheen, P Ernest, B Jandrain
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1990
[Eating before, during and after physical exercise in normal and diabetic subjects]B Jandrain, P Lefebvre, F Pirnay, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1992
[Postprandial hypoglycemia and alcohol drinking]P J Lefebvre, B Jandrain, A J Scheen
Diabete & Metabolisme|March 1, 1988
[Adaptation to sports by insulin-treated diabetics]B Jandrain, F Pirnay, A Scheen, et al.
The American Journal of Medicine|April 27, 1992
Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertensionB Jandrain, C Herbaut, J C Depoorter, et al.
Pageof 4